ALEXANDRIA, VA, March 2, 2016 – Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced that it served as a co-lender and documentation agent in the closing of a $35 million term loan and a $15 million revolving line of credit for Superior Biologics, Inc. (“Superior” or “the Company”). Funds are being used to support a recapitalization and refinancing of existing debt for the Company.
Superior Biologics is a leading home infusion and specialty pharmacy provider, offering services to pediatric and adult populations suffering from chronic illnesses. Superior services patients in a wide variety of disease states, most notably within the fields of neurology, immunology and hematology. Superior works closely with patients, manufacturers, payers and leading specialty physicians to provide multi-disciplinary patient care and customized treatment plans. Headquartered in Sharon Hill, Pennsylvania, the Company has a team of experienced professionals that provide services to patients throughout the United States.
“Oxford is pleased to have Superior Biologics as its newest leveraged finance client, and we greatly respect the Company’s management team, which has a track record for successfully building businesses in the infusion therapy space,” said Tracy S. Maziek, managing director at Oxford Finance. “Oxford is happy to provide funds to support this team’s commitment to deliver critical services to its patients.”
“Oxford has a strong reputation in the healthcare lending marketplace,” commented Mark A. Kovinsky, chief executive officer for Superior Biologics. “They delivered as promised and were critical to helping us achieve our business objectives with this credit facility.”
About Oxford Finance LLC
Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $3 billion in loans, with credit facilities ranging from $500 thousand to $75 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California and Massachusetts. For more information visit www.oxfordfinance.com.
About Superior Biologics, Inc.
Dedicated to wellness, Superior Biologics is a leading home infusion and specialty pharmacy provider offering services to pediatric and adult populations suffering from chronic illnesses. Superior Biologics’ goal is to provide cost-effective and highly compassionate care to its patients, leading to positive therapeutic outcomes and enhanced quality of life. For more information visit www.superiorbiologics.com.